130 related articles for article (PubMed ID: 6415168)
1. Identification of the apparently lymphocyte-specific human liver-derived inhibitory protein (LIP) as cytoplasmic liver L-arginase.
Brusdeilins M; Hapke C; Huberts HH; Schumacher K
J Immunol; 1983 Nov; 131(5):2427-31. PubMed ID: 6415168
[TBL] [Abstract][Full Text] [Related]
2. Evidence that an immunosuppressive protein from murine liver is arginase.
Huang MH; Yu CL; Han SH; Chiang BN; Wang SR
Biomed Biochim Acta; 1990; 49(4):179-87. PubMed ID: 2119573
[TBL] [Abstract][Full Text] [Related]
3. Purification and biochemical characterization of human liver-derived inhibitory protein (LIP).
Grol M; Schumacher K
J Immunol; 1983 Jan; 130(1):323-6. PubMed ID: 6401186
[TBL] [Abstract][Full Text] [Related]
4. Characterization of murine liver-derived inhibitory protein.
Wang SR; Huang MH; Chang KL; Yu CL; Chiang BN; Han SH
Scand J Immunol; 1990 Jan; 31(1):85-90. PubMed ID: 2105527
[TBL] [Abstract][Full Text] [Related]
5. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Singh R; Pervin S; Karimi A; Cederbaum S; Chaudhuri G
Cancer Res; 2000 Jun; 60(12):3305-12. PubMed ID: 10866325
[TBL] [Abstract][Full Text] [Related]
6. Arginase of Bacillus brevis Nagano: purification, properties, and implication in gramicidin S biosynthesis.
Kanda M; Ohgishi K; Hanawa T; Saito Y
Arch Biochem Biophys; 1997 Aug; 344(1):37-42. PubMed ID: 9244379
[TBL] [Abstract][Full Text] [Related]
7. Arginase release by primary hepatocytes and liver slices results in rapid conversion of arginine to urea in cell culture media.
Peters SJ; Haagsman HP; van Norren K
Toxicol In Vitro; 2008 Jun; 22(4):1094-8. PubMed ID: 18348903
[TBL] [Abstract][Full Text] [Related]
8. Allosteric regulation of beef liver arginase activity by L-ornithine.
Bedino S
Ital J Biochem; 1977; 26(4):264-76. PubMed ID: 562862
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of the EDTA-treated arginase from rat and calf liver.
Dahlig E; Porembska Z
Acta Biochim Pol; 1977; 24(3):187-96. PubMed ID: 412382
[TBL] [Abstract][Full Text] [Related]
10. Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors.
Reczkowski RS; Ash DE
Arch Biochem Biophys; 1994 Jul; 312(1):31-7. PubMed ID: 8031143
[TBL] [Abstract][Full Text] [Related]
11. Hyperoxia increases hepatic arginase expression and ornithine production in mice.
Malleske DT; Rogers LK; Velluci SM; Young TL; Park MS; Long DW; Welty SE; Smith CV; Nelin LD
Toxicol Appl Pharmacol; 2006 Aug; 215(1):109-17. PubMed ID: 16554078
[TBL] [Abstract][Full Text] [Related]
12. Purification of murine liver-derived inhibitory protein.
Wang SR; Huang MH; Chang KL; Tsai CY; Lin HY; Yu CL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):179-87. PubMed ID: 3149573
[TBL] [Abstract][Full Text] [Related]
13. Purification of human hepatic arginase and its manganese (II)-dependent and pH-dependent interconversion between active and inactive forms: a possible pH-sensing function of the enzyme on the ornithine cycle.
Kuhn NJ; Ward S; Piponski M; Young TW
Arch Biochem Biophys; 1995 Jun; 320(1):24-34. PubMed ID: 7793981
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of a new arginase from chicken liver: inactivation by ATP.
Grazi E; Rossi N; Sangiorgi G
Ital J Biochem; 1969; 18(6):426-38. PubMed ID: 5380349
[No Abstract] [Full Text] [Related]
15. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.
Dillon BJ; Holtsberg FW; Ensor CM; Bomalaski JS; Clark MA
Med Sci Monit; 2002 Jul; 8(7):BR248-53. PubMed ID: 12118186
[TBL] [Abstract][Full Text] [Related]
16. Identification of arginase in human placental villi.
Ishikawa T; Harada T; Koi H; Kubota T; Azuma H; Aso T
Placenta; 2007; 28(2-3):133-8. PubMed ID: 16720041
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lymphocyte proliferation by liver arginase.
Huang MH; Yang CC; Wang SR
Life Sci; 1992; 51(22):1725-30. PubMed ID: 1435081
[TBL] [Abstract][Full Text] [Related]
18. [Effect of pH and activation on the arginase activity of rat liver treated with thioacetamide].
Feijóo B; Aylagas H; Cascales M; Santos-Ruiz A
Rev Esp Fisiol; 1982; 38 Suppl():123-7. PubMed ID: 7146566
[TBL] [Abstract][Full Text] [Related]
19. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
[TBL] [Abstract][Full Text] [Related]
20. Liver arginase activity and plasma urea-nitrogen in lambs fed thyroprotein.
Katanyukul PJ; Boling JA; Nuzum CT
Int J Vitam Nutr Res; 1974; 44(3):415-20. PubMed ID: 4459293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
